Country: United States
Language: English
Source: NLM (National Library of Medicine)
PHENAZOPYRIDINE HYDROCHLORIDE (UNII: 0EWG668W17) (PHENAZOPYRIDINE - UNII:K2J09EMJ52)
Denton Pharma, Inc. dba Northwind Pharmaceuticals
ORAL
PRESCRIPTION DRUG
Phenazopyridine HCL is indicated for the symptomatic relief of pain, burning, urgency frequency, and other discomforts arising from irritation of the mucosa of the lower urinary tract caused by infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters. The use of Phenazopyridine for relief of symptoms should not delay definitive diagnosis and treatment of causative conditions. The drug should be used for symptomatic relief of pain and not as a substitute for specific surgery or antimicrobial therapy. Phenazopyridine is compatible with antimicrobial therapy and can help relieve pain and discomfort during the interval before antimicrobial therapy controls the infection. Treatment of a urinary tract infection with Phenazopyridine should not exceed 2 days. There is no evidence that the combined administration of Phenazopyridine and an antimicrobial provides greater benefit than administration of the antimicrobial alone after 2 days. (See Dosage and Administration.) In p
Dispense contents with a child-resistant closure (as required) and in a tight container as defined in the USP. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature]. NDC 70934-740-12 100 mg, 12 count - Appearance: Reddish-brown, round, film coated tablets debossed "812" on one side and plain on the other. To report an adverse reaction, please contact Westminster Pharmaceuticals, LLC at 1-844-221-7294 KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN.
unapproved drug other
PHENAZOPYRIDINE HYDROCHLORIDE- PHENAZOPYRIDINE HYDROCHLORIDE TABLET, FILM COATED DENTON PHARMA, INC. DBA NORTHWIND PHARMACEUTICALS _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- PHENAZOPYRIDINE HYDROCHLORIDE TABLETS, USP RX ONLY PHENAZOPYRIDINE HYDROCHLORIDE – WESTMINSTER PHARMACEUTICALS, LLC Prescription Medications PHENAZOPYRIDINE HYDROCHLORIDE, USP PHENAZOPYRIDINE HYDROCHLORIDE PHENAZOPYRIDINE HYDROCHLORIDE TABLET WESTMINSTER PHARMACEUTICALS LLC. DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. Label 100 mg, Label 200 mg RX ONLY DESCRIPTION Phenazopyridine Hydrochloride is a reddish-brown, odorless, slightly bitter, crystalline powder. It has a specific local analgesic effect in the urinary tract, promptly relieving burning and pain. Following is the structural formula: Phenazopyridine HCl oral tablets contain the following inactive ingredients: Crospovidone, Macrogol, Polysorbate 80, Polyvinyl Alcohol, Talc. CLINICAL PHARMACOLOGY Phenazopyridine hydrochloride is excreted in the urine where it exerts a topical analgesic effect on the mucosa of the urinary tract. This action helps to relieve pain, burning, urgency and frequency. The precise mechanism of action is unknown. PHARMACOKINETICS The pharmacokinetic properties of Phenazopyridine hydrochloride have not been determined. Phenazopyridine and its metabolites are rapidly excreted by the kidneys. In a small number of healthy subjects, 90% of a 600 mg/day oral dose of Phenazopyridine hydrochloride was eliminated in the urine in 24 hours, 41% as unchanged drug and 49% as metabolites. in 24 hours, 41% as unchanged drug and 49% as metabolites. INDICATIONS AND USAGE Phenazopyridine HCL is indicated for the symptomatic relief of pain, burning, urgency frequency, and other discomforts arising from irritation of the mucosa of the lower urinary tr Read the complete document